The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
The impact of VEGF on cancer metastasis and systemic disease
Open accessAbstract
Metastasis is the leading cause of cancer-associated mortality and the underlying mechanisms of cancer metastasis remain elusive. Both blood and lymphatic vasculatures are essential structures for mediating distal metastasis. The vasculature plays multiple functions, including accelerating tumor growth, sustaining the tumor microenvironment, supplying growth and invasive signals, promoting metastasis, and causing cancer-associated systemic disease. VEGF is one of the key angiogenic factors in tumors and participates in the initial stage of tumor development, progression and metastasis. Consequently, VEGF and its receptor-mediated signaling pathways have become one of the most important therapeutic targets for treating various cancers. Today, anti-VEGF-based antiangiogenic drugs (AADs) are widely used in the clinic for treating different types of cancer in human patients. Despite nearly 20-year clinical experience with AADs, the impact of these drugs on cancer metastasis and systemic disease remains largely unknown. In this review article, we focus our discussion on tumor VEGF in cancer metastasis and systemic disease and mechanisms underlying AADs in clinical benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Sternberg, C. N., Davis, I. D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C. H., Salman, P., Gladkov, O. A., Kavina, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9764 · Cited by 2,471
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Wilke, H., Muro, K., Van Cutsem, E., Oh, S.-C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,438
Adipocytes as regulators of energy balance and glucose homeostasis
Rosen, E. D., & Spiegelman, B. M. (2006) · Nature · doi:10.1038/nature05483 · Cited by 2,170
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Adipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Friedl, P., & Alexander, S. (2011) · Cell · doi:10.1016/j.cell.2011.11.016 · Cited by 1,940
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Rini, B. I., Escudier, B., Tomczak, P., Kaprin, A., Szczylik, C., Hutson, T. E., Michaelson, M. D., Gorbunova, V. A., Gore, M. E., Rusakov, I. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61613-9 · Cited by 1,840
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Cancer cachexia: understanding the molecular basis
Argilés, J. M., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3829 · Cited by 1,517
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Multistep Nature of Metastatic Inefficiency
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., & Groom, A. C. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65628-3 · Cited by 1,243
Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., & Condeelis, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,188
Angiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair
Johnson, K. E., & Wilgus, T. A. (2014) · Advances in Wound Care · doi:10.1089/wound.2013.0517 · Cited by 1,100
Gavard, J., & Gutkind, J. S. (2006) · Nature Cell Biology · doi:10.1038/ncb1486 · Cited by 1,018
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.
Maglione, D., Guerriero, V, Viglietto, G., Delli-Bovi, P., & Persico, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9267 · Cited by 999
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953
Motzer, R. J., Hutson, T. E., Glen, H., Michaelson, M. D., Molina, A., Eisen, T., Jassem, J., Zolnierek, J., Maroto, J. P., Mellado, B., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00290-9 · Cited by 945
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.2.261 · Cited by 903
Lymph protects metastasizing melanoma cells from ferroptosis
Ubellacker, J. M., Tasdogan, A., Ramesh, V., Shen, B., Mitchell, E. C., Martin-Sandoval, M. S., Gu, Z., McCormick, M. L., Durham, A. B., Spitz, D. R., et al. (2020) · Nature · doi:10.1038/s41586-020-2623-z · Cited by 896
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., & Detmar, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041896 · Cited by 719
Targeting VEGF/VEGFR to modulate antitumor immunity
Yang, J., Yan, J., & Liu, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00978 · Cited by 646
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R. S., Angle, N., et al. (2008) · Nature · doi:10.1038/nature07424 · Cited by 629
Harney, A. S., Arwert, E. N., Entenberg, D., Wang, Y., Guo, P., Qian, B.-Z., Oktay, M. H., Pollard, J. W., Jones, J. G., & Condeelis, J. S. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0012 · Cited by 618
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Roskoski, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.006 · Cited by 599
Vascular endothelial growth factor C induces angiogenesis in vivo
Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.-H., Claesson-Welsh, L., & Alitalo, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14389 · Cited by 565
Self-citationShields, J. D., Fleury, M. E., Yong, C., Tomei, A. A., Randolph, G. J., & Swartz, M. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.020 · Cited by 552
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
Ohm, J. E., Gabrilovich, D. I., Sempowski, G. D., Kisseleva, E., Parman, K. S., Nadaf, S., & Carbone, D. P. (2003) · Blood · doi:10.1182/blood-2002-07-1956 · Cited by 538
VEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
Hirakawa, S., Brown, L. F., Kodama, S., Paavonen, K., Alitalo, K., & Detmar, M. (2007) · Blood · doi:10.1182/blood-2006-05-021758 · Cited by 533
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
Song, E., Mao, T., Dong, H., Boisserand, L. S. B., Antila, S., Bosenberg, M., Alitalo, K., Thomas, J.-L., & Iwasaki, A. (2020) · Nature · doi:10.1038/s41586-019-1912-x · Cited by 532
Cardiac lymphatics are heterogeneous in origin and respond to injury
Klotz, L., Norman, S., Vieira, J. M., Masters, M., Rohling, M., Dubé, K. N., Bollini, S., Matsuzaki, F., Carr, C. A., & Riley, P. R. (2015) · Nature · doi:10.1038/nature14483 · Cited by 506
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Patrolling monocytes control tumor metastasis to the lung
Hanna, R. N., Cekic, C., Sag, D., Tacke, R., Thomas, G. D., Nowyhed, H., Herrley, E., Rasquinha, N., McArdle, S., Wu, R., et al. (2015) · Science · doi:10.1126/science.aac9407 · Cited by 480
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Saharinen, P., Eklund, L., Pulkki, K., Bono, P., & Alitalo, K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.015 · Cited by 478
Weis, S., Cui, J., Barnes, L., & Cheresh, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477
Pereira, E. R., Kedrin, D., Seano, G., Gautier, O., Meijer, E. F. J., Jones, D., Chin, S.-M., Kitahara, S., Bouta, E. M., Chang, J., et al. (2018) · Science · doi:10.1126/science.aal3622 · Cited by 477
Significance of blood vessel leakiness in cancer.
McDonald, D. M., & Bałuk, P. (2002) · PubMed · Cited by 465
Placke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H.-G., Kopp, H.-G., & Salih, H. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1872 · Cited by 458
Miquerol, L., Langille, B. L., & Nagy, A. (2000) · Development · doi:10.1242/dev.127.18.3941 · Cited by 429
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
Brown, M., Assen, F. P., Leithner, A., Abe, J., Schachner, H., Asfour, G., Bago-Horvath, Z., Stein, J. V., Uhrin, P., Sixt, M., et al. (2018) · Science · doi:10.1126/science.aal3662 · Cited by 417
He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., Harding, T., Jooss, K., Takahashi, T., & Alitalo, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4576 · Cited by 410
Harrell, M. I., Iritani, B. M., & Ruddell, A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060761 · Cited by 388
Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span
Grunewald, M., Kumar, S., Sharife, H., Volinsky, E., Gileles-Hillel, A., Licht, T., Permyakova, A., Hinden, L., Azar, S., Friedmann, Y., et al. (2021) · Science · doi:10.1126/science.abc8479 · Cited by 379
VEGF as a Mediator of Tumor-Associated Immunodeficiency
Ohm, J. E., & Carbone, D. P. (2001) · Immunologic Research · doi:10.1385/ir:23:2-3:263 · Cited by 371
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis
Fukumura, D., Ushiyama, A., Duda, D. G., Xu, L., Tam, J., Krishna, V., Chatterjee, K., Garkavtsev, I., & Jain, R. K. (2003) · Circulation Research · doi:10.1161/01.res.0000099243.20096.fa · Cited by 365
Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1392 · Cited by 361
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Wang, D., Sun, H., Wei, J., Cen, B., & DuBois, R. N. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3199 · Cited by 356
VEGF-A and Tenascin-C produced by S100A4 + stromal cells are important for metastatic colonization
O'Connell, J. T., Sugimoto, H., Cooke, V. G., MacDonald, B. A., Mehta, A. I., LeBleu, V. S., Dewar, R., Rocha, R. M., Brentani, R. R., Resnick, M. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109493108 · Cited by 348
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
Correia, A. L., Guimaraes, J. C., Auf der Maur, P., De Silva, D., Trefny, M. P., Okamoto, R., Bruno, S., Schmidt, A., Mertz, K., Volkmann, K., et al. (2021) · Nature · doi:10.1038/s41586-021-03614-z · Cited by 339
Elias, I., Franckhauser, S., Ferré, T., Vilà, L., Tafuro, S., Muñoz, S., Roca, C., Ramos, D., Pujol, A., Riu, E., et al. (2012) · Diabetes · doi:10.2337/db11-0832 · Cited by 320
Cao, Y. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.008 · Cited by 319
Self-citationQian, C.-N., Berghuis, B., Tsarfaty, G., Bruch, M., Kort, E. J., Ditlev, J., Tsarfaty, I., Hudson, E., Jackson, D. G., Petillo, D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2977 · Cited by 312
Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D
Yamada, Y., Nezu, J.-I., Shimane, M., & Hirata, Y. (1997) · Genomics · doi:10.1006/geno.1997.4774 · Cited by 300
Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance
Iwamoto, H., Abe, M., Yang, Y., Cui, D., Seki, T., Nakamura, M., Hosaka, K., Lim, S., Wu, J., He, X., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.005 · Cited by 300
Self-citationDiverse roles for VEGF-A in the nervous system
Mackenzie, F., & Ruhrberg, C. (2012) · Development · doi:10.1242/dev.072348 · Cited by 294
Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
Cao, Y. (2009) · Science Signaling · doi:10.1126/scisignal.259re1 · Cited by 289
Self-citationWebb, N. J. A., Bottomley, M. J., Watson, C. J., & Brenchley, P. E. C. (1998) · Clinical Science · doi:10.1042/cs0940395 · Cited by 286
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
Bonde, A.-K., Tischler, V., Kumar, S., Soltermann, A., & Schwendener, R. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-35 · Cited by 283
Hereditary lymphedema: evidence for linkage and genetic heterogeneity
Ferrell, R. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2073 · Cited by 282
Horikawa, N., Abiko, K., Matsumura, N., Hamanishi, J., Baba, T., Yamaguchi, K., Yoshioka, Y., Koshiyama, M., & Konishi, I. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0387 · Cited by 275
Molecular Control of Lymphatic Metastasis
Achen, M. G., & Stacker, S. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.020 · Cited by 260
Cao, Y., O'Reilly, M. S., Marshall, B., Flynn, E., Ji, R. W., & Folkman, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1558 · Cited by 253
Self-citationDikov, M. M., Ohm, J. E., Ray, N., Tchekneva, E. E., Burlison, J., Moghanaki, D., Nadaf, S., & Carbone, D. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.215 · Cited by 244
Massena, S., Christoffersson, G., Vågesjö, E., Seignez, C., Gustafsson, K., Binet, F., Herrera Hidalgo, C., Giraud, A., Lomei, J., Weström, S., et al. (2015) · Blood · doi:10.1182/blood-2015-03-631572 · Cited by 243
Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R., & Giaccia, A. J. (1996) · PubMed · Cited by 239
Robciuc, M. R., Kivelä, R., Williams, I. M., de Boer, J. F., van Dijk, T. H., Elamaa, H., Tigistu-Sahle, F., Molotkov, D., Leppänen, V.-M., Käkelä, R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.004 · Cited by 234
Sun, X., He, X., Zhang, Y., Hosaka, K., Andersson, P., Wu, J., Wu, J., Jing, X., Du, Q., Hui, X., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-322744 · Cited by 233
Self-citationLi, B., Lalani, A. S., Harding, T. C., Luan, B., Koprivnikar, K., Huan Tu, G., Prell, R., VanRoey, M. J., Simmons, A. D., & Jooss, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1558 · Cited by 232
Vascular endothelial growth factor in heart failure
Taimeh, Z., Loughran, J., Birks, E. J., & Bolli, R. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.94 · Cited by 231
The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
Bruno, A., Focaccetti, C., Pagani, A., Imperatori, A. S., Spagnoletti, M., Rotolo, N., Cantelmo, A. R., Franzi, F., Capella, C., Ferlazzo, G., et al. (2013) · Neoplasia · doi:10.1593/neo.121758 · Cited by 230
Alfaro, C., Suarez, N., Gonzalez, A., Solano, S., Erro, L., Dubrot, J., Palazon, A., Hervas-Stubbs, S., Gurpide, A., Lopez-Picazo, J. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604965 · Cited by 214
Verheul, H. M. W., Jorna, A. S., Hoekman, K., Broxterman, H. J., Gebbink, M. F. B. G., & Pinedo, H. M. (2000) · Blood · doi:10.1182/blood.v96.13.4216 · Cited by 210
Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects
Detoraki, A., Staiano, R. I., Granata, F., Giannattasio, G., Prevete, N., de Paulis, A., Ribatti, D., Genovese, A., Triggiani, M., & Marone, G. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.01.044 · Cited by 208
Tumor Microenvironment of Metastasis and Risk of Distant Metastasis of Breast Cancer
Rohan, T. E., Xue, X., Lin, H.-M., D’Alfonso, T. M., Ginter, P. S., Oktay, M. H., Robinson, B. D., Ginsberg, M., Gertler, F. B., Glass, A. G., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju136 · Cited by 202
Xu, X. R., Carrim, N., Neves, M. A. D., McKeown, T., Stratton, T. W., Coelho, R. M. P., Lei, X., Chen, P., Xu, J., Dai, X., et al. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0100-6 · Cited by 199
Wey, J. S., Fan, F., Gray, M. J., Bauer, T. W., McCarty, M. F., Somcio, R., Liu, W., Evans, D. B., Wu, Y., Hicklin, D. J., et al. (2005) · Cancer · doi:10.1002/cncr.21145 · Cited by 194
Hegde, P. S., Jubb, A. M., Chen, D., Li, N. F., Meng, Y. G., Bernaards, C., Elliott, R., Scherer, S. J., & Chen, D. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2535 · Cited by 193
Whole exome sequencing reveals the major genetic contributors to nonsyndromic tetralogy of Fallot
Page, D. J., Miossec, M. J., Williams, S. G., Monaghan, R. M., Fotiou, E., Cordell, H. J., Sutcliffe, L., Topf, A., Bourgey, M., Bourque, G., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313250 · Cited by 189
Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer
Yeo, E.-J., Cassetta, L., Qian, B.-Z., Lewkowich, I., Li, J.-F., Stefater, J. A., Smith, A. N., Wiechmann, L. S., Wang, Y., Pollard, J. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2421 · Cited by 187
Yang, Y., Andersson, P., Hosaka, K., Zhang, Y., Cao, R., Iwamoto, H., Yang, X., Nakamura, M., Wang, J., Zhuang, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11385 · Cited by 186
Self-citationJi, H., Cao, R., Yang, Y., Zhang, Y., Iwamoto, H., Lim, S., Nakamura, M., Andersson, P., Wang, J., Sun, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms5944 · Cited by 184
Self-citationTargeting VEGF in eye neovascularization: What's new?
Amadio, M., Govoni, S., & Pascale, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 175
Ziogas, A. C., Gavalas, N. G., Tsiatas, M., Tsitsilonis, O., Politi, E., Terpos, E., Rodolakis, A., Vlahos, G., Thomakos, N., Haidopoulos, D., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26094 · Cited by 168
Jubb, A. M., Pham, T. Q., Hanby, A. M., Frantz, G. D., Peale, F. V., Wu, T. D., Koeppen, H. W., & Hillan, K. J. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.012963 · Cited by 163
Oda, Y., Yamamoto, H., Tamiya, S., Matsuda, S., Tanaka, K., Yokoyama, R., Iwamoto, Y., & Tsuneyoshi, M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800587 · Cited by 162
Redefining macrophage and neutrophil biology in the metastatic cascade
Güç, E., & Pollard, J. W. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.022 · Cited by 157
Functional significance of VEGFR‐2 on ovarian cancer cells
Spannuth, W. A., Nick, A. M., Jennings, N. B., Armaiz-Peña, G. N., Mangala, L. S., Danes, C. G., Lin, Y. G., Merritt, W. M., Thaker, P. H., Kamat, A. A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24028 · Cited by 153
Kallergi, G., Markomanolaki, H., Giannoukaraki, V., Papadaki, M. A., Strati, A. D., Lianidou, E. S., Georgoulias, V., Mavroudis, D., & Agelaki, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2452 · Cited by 152
Cao, Y. (2004) · The biomedical & life sciences collection. · doi:10.1016/j.semcancer.2003.09.018 · Cited by 148
Self-citationAnti-VEGF– and anti-VEGF receptor–induced vascular alteration in mouse healthy tissues
Yang, Y., Zhang, Y., Cao, Z., Ji, H. L., Yang, X., Iwamoto, H., Wahlberg, E., Länne, T., Sun, B., & Cao, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301331110 · Cited by 143
Self-citationTargeting angiogenesis and lymphangiogenesis in kidney disease
Tanabe, K., Wada, J., & Sato, Y. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0260-2 · Cited by 140
VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
Suzuki, H. Y., Onishi, H., 和田, 純., Yamasaki, A., Tanaka, H., Nakano, K., Morisaki, T., & Katano, M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939887 · Cited by 136
Epithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
López‐Soto, A., Huergo-Zapico, L., Galván, J. A., Rodrigo, L., de Herreros, A. G., Astudillo, A., & Gonzalez, S. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202950 · Cited by 131
Jin-no, K., Tanimizu, M., Hyodo, I., Nishikawa, Y., Hosokawa, Y., Doi, T., Endo, H., Yamashita, T., & Okada, Y. (1998) · Journal of Gastroenterology · doi:10.1007/s005350050099 · Cited by 126
Alishekevitz, D., Gingis‐Velitski, S., Kaidar‐Person, O., Gutter-Kapon, L., Scherer, S. D., Raviv, Z., Merquiol, E., Ben‐Nun, Y., Miller, V., Rachman-Tzemah, C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.083 · Cited by 121
Karaman, S., Hollmén, M., Robciuc, M. R., Alitalo, A. K., Nurmi, H. J., Morf, B., Buschle, D., Alkan, H. F., Ochsenbein, A. M., Alitalo, K. K., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.006 · Cited by 115
Yang, Y., Zhang, Y., Iwamoto, H., Hosaka, K., Seki, T., Andersson, P., Lim, S., Fischer, C., Nakamura, M., Abe, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12680 · Cited by 114
Self-citationThe pivotal role of VEGF in adipose-derived-stem-cell-mediated regeneration
Song, S. Y., Chung, H., & Sung, J.-H. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.522987 · Cited by 110
VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs
Cao, Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.114 · Cited by 109
Self-citationAncelin, M., Chollet‐Martin, S., Hervé, M. A., Legrand, C., Benna, J. E., & Perrot‐Applanat, M. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700053 · Cited by 105
Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas
Connell, F., Østergaard, P., Carver, C., Brice, G. W., Williams, N., Mansour, S., Mortimer, P. S., & Jeffery, S. (2008) · Human Genetics · doi:10.1007/s00439-008-0586-5 · Cited by 99
Schöffski, P., Elisei, R., Müller, S. P., Brose, M. S., Shah, M. H., Licitra, L. F., Jarząb, B., Медведев, В. С., Kreissl, M. C., Niederle, B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.5508 · Cited by 92
Rutkowski, J. M., Markhus, C. E., Gyenge, C. C., Alitalo, K. K., Wiig, H., & Swartz, M. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090733 · Cited by 90
Optimizing the Delivery of Cancer Drugs That Block Angiogenesis
Cao, Y., & Langer, R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000399 · Cited by 89
Self-citationAblation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning
Seki, T., Hosaka, K., Fischer, C., Lim, S., Andersson, P., Abe, M., Iwamoto, H., Gao, Y., Wang, X., Fong, G., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171012 · Cited by 89
Self-citationVascular endothelial growth factor for in vivo bone formation: A systematic review
Dreyer, C. H., Kjærgaard, K., Ding, M. L., & Qin, L. (2020) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2020.05.005 · Cited by 84
Metastasis as a systemic disease: molecular insights and clinical implications
Alečković, M., McAllister, S. S., & Polyák, K. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.06.002 · Cited by 82
Steenbrugge, J., Elst, N. V., Demeyere, K., Wever, O. D., Sanders, N. N., Broeck, W. V. D., Dirix, L. Y., Laere, S. V., & Meyer, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02928 · Cited by 78
VEGFR1-activity-independent metastasis formation
Dawson, M., Duda, D. G., Fukumura, D., & Jain, R. K. (2009) · Nature · doi:10.1038/nature08254 · Cited by 77
Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome
Wong, A. K., Alfert, M., Castrillón, D. H., Shen, Q. “., Holash, J. A., Yancopoulos, G. D., & Chin, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121192298 · Cited by 75
Cao, Y., Zhong, W., & Sun, Y. P. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.05.001 · Cited by 74
Self-citationCD146 mediates VEGF ‐induced melanoma cell extravasation through FAK activation
Jouve, N., Bachelier, R., Despoix, N., Blin, M. G., Matinzadeh, M. K., Poitevin, S., Aurrand‐Lions, M., Fallague, K., Bardin, N., Blot‐Chabaud, M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29370 · Cited by 69
Subauste, M. C., Kupriyanova, T. A., Conn, E. M., Ardi, V. C., Quigley, J. P., & Deryugina, E. I. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9293-4 · Cited by 65
Honek, J., Seki, T., Iwamoto, H., Fischer, C., Li, J., Lim, S., Samani, N. J., Zang, J., & Cao, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415825111 · Cited by 61
Self-citationRamamoorthy, P., Thomas, S. M., Kaushik, G., Subramaniam, D., Chastain, K. M., Dhar, A., Tawfik, O. W., Kasi, A., Sun, W., Ramalingam, S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2602 · Cited by 57
Off-tumor target—beneficial site for antiangiogenic cancer therapy?
Cao, Y. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.118 · Cited by 56
Self-citationMegakaryocytes Mediate Hyperglycemia-Induced Tumor Metastasis
Wu, B., Ye, Y., Xie, S., Li, Y., Sun, X., Lv, M., Yang, L., Cui, N., Chen, Q., Jensen, L. D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1180 · Cited by 37
Self-citationZhang, Y., Yang, Y., Hosaka, K., Huang, G., Zang, J., Chen, F., Zhang, Y., Samani, N. J., & Cao, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601649113 · Cited by 34
Self-citationDing, G., Feng, C., Song, N., Fang, Z., Xia, G., Jiang, H., Hua, L.-X., & Ding, Q. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.03.021 · Cited by 33
Endothelial cell-initiated extravasation of cancer cells visualized in zebrafish
Kanada, M., Zhang, J., Yan, L., Sakurai, T., & Terakawa, S. (2014) · PeerJ · doi:10.7717/peerj.688 · Cited by 33
Tumor-derived VEGF modulates hematopoiesis
Xue, Y., Chen, F., Zhang, D., Lim, S., & Cao, Y. (2009) · Vascular Cell · doi:10.1186/2040-2384-1-9 · Cited by 31
Self-citationCervi, D. N., Shaked, Y., Haeri, M., Usenko, T. S., Lee, C. R., Haigh, J. J., Nagy, A., Kerbel, R. S., Yefenof, E., & Ben‐David, Y. (2006) · Blood · doi:10.1182/blood-2005-11-026823 · Cited by 27
Hattori, K., Ito, Y., Honda, M., Sekiguchi, K., Hosono, K., Shibuya, M., Unno, N., & Majima, M. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.05.003 · Cited by 27
Bussard, K. M., Okita, N., Sharkey, N. A., Neuberger, T., WEBB, A. G., & Mastro, A. M. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9330-3 · Cited by 26
Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia
Lee, J. Y., Park, S., Min, W.-S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.027 · Cited by 26
Characterizing Lymphangiogenesis and Concurrent Inflammation in Adipose Tissue in Response to VEGF-D
Chakraborty, A., Scogin, C., Rizwan, K., Morley, T. S., & Rutkowski, J. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00363 · Cited by 20
Muramatsu, M., Akakura, S., Gao, L., Peresie, J., Balderman, B., & Gelman, I. H. (2018) · Oncotarget · doi:10.18632/oncotarget.26067 · Cited by 11
Krebs, R., Tikkanen, J., Raissadati, A., Hollmén, M., Dhaygude, K., & Lemström, K. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.10.018 · Cited by 5
Cited by
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Metadata
- Authors
- Yang, Y., & Cao, Y.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 86
- Issue
- Pt 3
- Pages
- 251-261
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W4220851453
- Cited by
- 286
- References
- 155
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.